1131 related articles for article (PubMed ID: 18378430)
1. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
Pletz MW; Maus U; Krug N; Welte T; Lode H
Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
[TBL] [Abstract][Full Text] [Related]
2. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
[TBL] [Abstract][Full Text] [Related]
3. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
Pletz MW; Maus U; Hohlfeld JM; Lode H; Welte T
Dtsch Med Wochenschr; 2008 Feb; 133(8):358-62. PubMed ID: 18270917
[TBL] [Abstract][Full Text] [Related]
4. [Pneumococcal vaccine: protection of adults and reduction of antibiotic resistence by vaccination of children with a conjugated vaccine].
Pletz MW
Med Monatsschr Pharm; 2011 Jun; 34(6):201-5. PubMed ID: 21812250
[TBL] [Abstract][Full Text] [Related]
5. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
Dagan R
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal vaccines: World Health Organization position paper.
Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
[TBL] [Abstract][Full Text] [Related]
7. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
[TBL] [Abstract][Full Text] [Related]
8. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
9. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
Toltzis P; Jacobs MR
Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
12. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
15. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
Zangeneh TT; Baracco G; Al-Tawfiq JA
Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
[TBL] [Abstract][Full Text] [Related]
16. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
Motlova J; Benes C; Kriz P
Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
[TBL] [Abstract][Full Text] [Related]
17. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
[TBL] [Abstract][Full Text] [Related]
18. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
[TBL] [Abstract][Full Text] [Related]
19. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
Picazo JJ
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
[TBL] [Abstract][Full Text] [Related]
20. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine.
Calbo E; Díaz A; Cañadell E; Fábrega J; Uriz S; Xercavins M; Morera MA; Cuchi E; Rodríguez-Carballeira M; Garau J;
Clin Microbiol Infect; 2006 Sep; 12(9):867-72. PubMed ID: 16882291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
